Nectero Medical, Inc.

📍 Tempe, United States🗓 Founded 2017👥 27 employees💰 Last funded Apr 2024
Medical Equipment Manufacturing🌐 necteromedical.com
Website LinkedIn
Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST®, or Endovascular Aneurysm Stabilization Treatment System, delivers a compound with a proprietary molecule known as a Stabilizer Agent to the site of the aneurysm. The Stabilizing Agent: * Inhibits further breakdown of the aneurysm by disrupting the “aortic degradation process”. * Strengthens the vessel wall by cross-linking within the tissue; this wall strengthening lowers the risk of rupture. Our technology allows for earlier intervention in a much safer manner; this can prevent or significantly delay the need for major endovascular (EVAR) or surgical repair. By preventing further degradation of the aneurysm and strengthening the aortic tissue around the aneurysm, many patients can live out their normal life span and never need to face the challenges of EVAR or Surgical repair.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Nectero Medical, Inc.?
Nectero Medical, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Nectero Medical, Inc. last raise funding?
The most recent investment in Nectero Medical, Inc. recorded on gritt.io was in April 2024.
When was Nectero Medical, Inc. founded?
Nectero Medical, Inc. was founded in 2017.
What industry is Nectero Medical, Inc. in?
Nectero Medical, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Nectero Medical, Inc. based?
Nectero Medical, Inc. is headquartered in Tempe, United States.